PA
Perceptive Advisors Portfolio holdings
AUM
$2.67B
This Quarter Return
+20.34%
1 Year Return
+73.17%
3 Year Return
+837.18%
5 Year Return
+928.4%
10 Year Return
+11,818.45%
AUM
$891M
AUM Growth
+$891M
(+10%)
Cap. Flow
-$1.62M
Cap. Flow
% of AUM
-0.18%
Top 10 Holdings %
Top 10 Hldgs %
48.29%
Holding
160
New
50
Increased
18
Reduced
30
Closed
32
Top Buys
| 1 |
Iovance Biotherapeutics
IOVA
|
$28.3M |
| 2 |
Heron Therapeutics
HRTX
|
$24.5M |
| 3 |
PTC Therapeutics
PTCT
|
$17.6M |
| 4 |
Acadia Pharmaceuticals
ACAD
|
$16.2M |
| 5 |
ARAV
Aravive, Inc. Common Stock
ARAV
|
$15.1M |
Top Sells
| 1 |
CELG
Celgene Corp
CELG
|
$42.3M |
| 2 |
AEGR
Aegerion Pharmaceuticals, Inc.
AEGR
|
$31.8M |
| 3 |
MannKind Corp
MNKD
|
$19.8M |
| 4 |
Vertex Pharmaceuticals
VRTX
|
$16.3M |
| 5 |
Sarepta Therapeutics
SRPT
|
$14.6M |
Sector Composition
| 1 | Healthcare | 88.32% |
| 2 | Technology | 0.04% |
| 3 | Industrials | 0.02% |
| 4 | Consumer Discretionary | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Talphera
TLPH
$11.1M
| $79M | 8.3% | 6,574,060 | – | – |
|
2
Neurocrine Biosciences
NBIX
$13.8B
| $74.4M | 7.81% | 4,619,367 +435,630 | +10% | +$7.01M |
|
|
3
Sarepta Therapeutics
SRPT
$1.78B
| $69.2M | 7.27% | 2,878,979 -605,600 | -17% | -$14.6M |
|
|
4
Vertex Pharmaceuticals
VRTX
$100B
| $41.1M | 4.32% | 581,728 -230,000 | -28% | -$16.3M |
|
|
TSRO
5
DELISTED
TESARO, Inc.
TSRO
| $36.3M | 3.81% | 1,230,070 -216,500 | -15% | -$6.38M |
|
|
CELG
6
DELISTED
Celgene Corp
CELG
| $28.8M | 3.02% | 206,200 -303,000 | -60% | -$42.3M |
|
|
7
Iovance Biotherapeutics
IOVA
$807M
| $28.3M | 2.98% | +3,000,000 | New | +$28.3M |
|
8
Exact Sciences
EXAS
$8.98B
| $25.9M | 2.72% | 1,825,150 -144,753 | -7% | -$2.05M |
|
|
9
Heron Therapeutics
HRTX
$207M
| $24.5M | 2.58% | +1,762,426 | New | +$24.5M |
|
|
DYAX
10
DELISTED
DYAX CORPORATION
DYAX
| $23M | 2.42% | 2,562,674 +230,000 | +10% | +$2.07M |
|
11
Travere Therapeutics
TVTX
$1.56B
| $22.1M | 2.33% | 1,044,292 -8,400 | -0.8% | -$178K |
|
|
WBA
12
DELISTED
Walgreens Boots Alliance
WBA
| $20.1M | 2.11% | 304,419 -17,581 | -5% | -$1.16M |
|
|
COV
13
DELISTED
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
| $19.4M | 2.03% | 262,900 -111,926 | -30% | -$8.24M |
|
|
14
PTC Therapeutics
PTCT
$3.92B
| $17.6M | 1.84% | +671,736 | New | +$17.6M |
|
15
Xencor
XNCR
$580M
| $17.5M | 1.83% | 1,488,672 -80,000 | -5% | -$938K |
|
|
NEPT
16
DELISTED
Neptune Wellness Solutions Inc. Ordinary Shares
NEPT
| $16.6M | 1.74% | 6,700,444 +800,000 | +14% | +$1.98M |
|
|
17
Acadia Pharmaceuticals
ACAD
$4.38B
| $16.2M | 1.7% | +666,000 | New | +$16.2M |
|
|
ARAV
18
DELISTED
Aravive, Inc. Common Stock
ARAV
| $15.1M | 1.58% | +501,266 | New | +$15.1M |
|
19
Sangamo Therapeutics
SGMO
$157M
| $14.5M | 1.52% | +800,000 | New | +$14.5M |
|
20
Prothena Corp
PRTA
$441M
| $13.4M | 1.41% | +350,000 | New | +$13.4M |
|
|
ANAC
21
DELISTED
ANACOR PHARMACEUTICALS INC COM
ANAC
| $12.9M | 1.36% | 647,015 +159,473 | +33% | +$3.19M |
|
22
MacroGenics
MGNX
$112M
| $12.5M | 1.31% | 448,945 -268,760 | -37% | -$7.48M |
|
|
CLVS
23
DELISTED
Clovis Oncology, Inc.
CLVS
| $11.9M | 1.25% | 172,217 +141,632 | +463% | +$9.81M |
|
|
ZLTQ
24
DELISTED
ZELTIQ Aesthetics, Inc.
ZLTQ
| $11.5M | 1.21% | 586,013 +280,420 | +92% | +$5.5M |
|
25
Viatris
VTRS
$12.3B
| $11.4M | 1.19% | 232,500 -160,000 | -41% | -$7.81M |
|